China Acts To Block Fatal Fake Of Diabetes Drug Brand
This article was originally published in PharmAsia News
Executive Summary
Chinese food and drug authorities have arrested four people suspected of selling lethal fake copies of Tang Zhi Ning Jiao Nang, a drug for treating diabetes. The State FDA began a national search for other evidence of the drugs after two patients died in an autonomous province. The suspect drugs were found to contain glibenclamide, masked as a drug once made by Guangxi Pingnan Pharmaceutical. The SFDA ordered medical institutions to stop using the brand for diabetes until they could be checked and to record cases where the brand was used and submit samples to local inspection agencies. (Click here for more